Top award for milestone paper

By Hudson Institute communications

A landmark Nature study that sheds light on how E.coli wreaks havoc on the body has earned Hudson Institute researcher, Dr Jaclyn Pearson, one of the nation’s top scientific awards.

A landmark study that sheds light on how E.coli wreaks havoc on the body has earned Dr Jaclyn Pearson a top scientific awards.
Dr Jaclyn Pearson

The National Association of Research Fellows (NARF) awarded Dr Pearson the 2018 Postdoctoral Investigator Award for her research that shows how some types of E.coli shut down our gut cell’s natural ability to die, allowing bacteria to survive longer. This process potentially results in more severe illness in people.

Dr Pearson contributed to the research in collaboration with Professor Elizabeth Hartland and Dr Cristina Giogha in 2013 during the final year of her PhD. The work earned widespread recognition from the scientific community and is highly cited, as it demonstrated for the first time how bacteria can chemically modify cells in our gut. NARF awards the Postdoctoral Investigator Award annually to an early career postdoctoral researcher with the most outstanding publication within the past five years.

Dr Pearson said her contributions to the paper have become the foundation for her work at Hudson Institute, which focuses on understanding immune responses to bacterial gut infections. She described the acknowledgement as a great honour.

“A panel of top senior Australian research fellows select the award-winner, so it’s a privilege. I am proud of the work the team achieved to reach such a high standard that it was accepted in Nature,” Dr Pearson said.

Contact us

Hudson Institute communications
t: + 61 3 8572 2697

About Hudson Institute

Hudson Institute’ s research programs deliver in five areas of medical need – inflammation, cancer, reproductive health, newborn health, and hormones and health. More

Hudson News

Get the inside view on discoveries and patient stories

“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”

Alana Chantry